The summaries are free for public
use. The Chronic Liver Disease
Foundation will continue to add and
archive summaries of articles deemed
relevant to CLDF by the Board of
Trustees and its Advisors.
Abstract Details
Multimodality Imaging of Hepatocellular Carcinoma: From Diagnosis to Treatment Response Assessment in Everyday Clinical Practice
Can Assoc Radiol J. 2021 Nov;72(4):714-727. doi: 10.1177/0846537120923982.Epub 2020 May 21.
Andrea Delli Pizzi12, Domenico Mastrodicasa3, Roberta Cianci2, Francesco Lorenzo Serafini2, Erica Mincuzzi2, Francesca Di Fabio2, Alberto Giammarino2, Gianluca Mannetta2, Raffaella Basilico2, Massimo Caulo12
Author information
1ITAB-Institute of Advanced Biomedical Technologies, "9301G. d'Annunzio" University, Chieti, Italy.
2Department of Neuroscience, Imaging and Clinical Sciences, "9301G. d'Annunzio" University, Chieti, Italy.
3Department of Radiology, 10624Stanford University School of Medicine, Stanford, CA, USA.
Abstract
The Liver Imaging Reporting and Data System (LI-RADS) is a recently developed classification aiming to improve the standardization of liver imaging assessment in patients at risk of developing hepatocellular carcinoma (HCC). The LI-RADS v2017 implemented new algorithms for ultrasound (US) screening and surveillance, contrast-enhanced US diagnosis and computed tomography/magnetic resonance imaging treatment response assessment. A minor update of LI-RADS was released in 2018 to comply with the American Association for the Study of the Liver Diseases guidance recommendations. The scope of this review is to provide a practical overview of LI-RADS v2018 focused both on the multimodality HCC diagnosis and treatment response assessment.